Search results
Results from the WOW.Com Content Network
Starting with the launch of Revio in early 2023, we’ve been steadily executing on our strategy, building a portfolio of innovative products that address the full spectrum of research demands. This launch exemplifies how PacBio is raising the bar for data quality and accessibility, empowering more researchers to explore new scientific frontiers."
A PacBio RSII sequencer PacBio Revio long-read sequencer. The company's first scientific instrument, called the PacBio RS, was released to a limited set of customers in late 2010., with full commercial release in early 2011.
The study, led by Christian Gilissen and Lisenka Vissers of Radboudumc, used PacBio’s Revio platform and HiFi long reads to analyze 100 challenging patient samples where the genetic causes of rare diseases had been difficult to identify in previous investigations using short reads combined with various supplementary tests.
MENLO PARK, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the Global Institute for Food Security (GIFS) at the University of Saskatchewan (USask) as the first Revio PacBio Certified Service Provider (CSP) in Canada.
Scientists from Washington University used the Parabricks DeepVariant pipeline for identifying variants (e.g., SNPs and small indels) in long-read Hi-Fi whole-genome sequencing (WGS) data generated with PacBio's Revio SMRT Cell technology.
PacBio's (PACB) sequencing system enhances Radboudumc's SMRT sequencing capability through the addition of two new PacBio Sequel IIe systems.
PacBio's (PACB) latest acquisition is expected to deliver the most advanced blend of sequencing solutions to transform the genomics landscape.
New England Biolabs (NEB) is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. [2] It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. [3]